Side Image
 

Board & Committees

We are grateful to our Board, PHI Foundation and Committees for their commitment to steering PHI to continued success.

 

Board

 

Chairman
Dr Bob Edgar  BEcon (Hons), PhD (Econ), FAICD

Experience and expertise: Non-executive director and Chair. Extensive experience in financial services including 25 years at ANZ Bank where his final role was that of Deputy Chief Executive Officer.

Other current directorships: Asciano Group, Linfox Armaguard Pty Ltd, Nufarm Limited, Transurban Ltd, AMMB Holdings Berhad, Shanghai Rural Commercial Bank and Bank of Tianjin. 

Special responsibilities Chair of the Board, Member of the Finance and Audit Committee and Chair of the Investment Committee.


Chief Executive Officer
Professor Matthew Gillespie BSc (Hons) PhD

Experience and expertise: Matt brought over 20 years research and leadership experience to the Institute when he became its CEO and fourth director in 2008, including nearly 20 years with St Vincent’s Institute of Medical Research with the last 9 as Associate Director. He is an internationally renowned researcher in the fields of bone, joint and cancer and a member of the Research Committee of the National Health Medical Research Council.

Other current directorships Ovarian Cancer Research Foundation, Australian and New Zealand Bone and Mineral Society and Monash Health Research Precinct Pty Ltd.

 

Special responsibilities: Chief Executive Officer, Member of Intellectual Property and Commercialisation Committee, Investment Committee and of the Foundation. 


Ms. Jane Bell B Ec, LLB, LLM

Experience and expertise: A Board member of the Company’s predecessor since 2002, Jane brought her experience and knowledge across to the Company including over 20 years legal experience in corporate treasury and financial services operations in Australia, UK, USA and Canada.
 
Other current directorships: Melbourne Health, WorkSafe Victoria, Westernport Water Corporation.

Special responsibilities: Chair of Intellectual Property and Commercialisation Committee.


Ms. Jennifer Joiner BEcon, CPA

Experience and expertise: Currently Customer Care Lead Asia Pacific for Life Technologies Jennifer has an extensive background in Australian and global life sciences businesses including senior executive positions at Idexx Labs, Bayer AG and GE Medical Systems Australia Pty Ltd.

Special responsibilities: Member of Intellectual Property and Commercialisation Committee.


Associate Professor Wayne Ramsey AM, CSC, MBBS, MHA, FRACMA

Experience and expertise: Wayne was a Board member of the Company’s predecessor since 2007.Following a successful military career, including the role of Director General Defence Health Service, Wayne moved into research, clinical and medical services and is   currently Executive Director of Medical Services and Quality for Southern Health. He has Board experience in companies involved in medical research and clinical service delivery.

Other current directorships: Kitya Board responsible for Jesse McPherson Hospital.

 Professor Christina Mitchell MBBS, PhD

Experience and expertise: Chris is currently the Dean of the Faculty of Medicine, Nursing and Health Sciences, Monash University. Chris has previously been the Head of the Department of Biochemistry and Molecular Biology, which quadrupled its size and research budget under her leadership, and as the Head of the School of Biomedical Sciences.

Professor Christina Mitchell trained as a physician scientist specialising in clinical haematology. She received her medical training from Melbourne University and consultant training in haematology at the Alfred Hospital, Melbourne. Her post-doctoral studies were undertaken in the field of intracellular signalling at Washington University Medical School, St Louis, USA.


Mr. John Weste BSc, MBA

Experience and expertise: Over 25 years general and line management and management consulting experience and expertise gained whilst working within global corporations and as a Partner/ Vice President in some of the world’s leading management consulting firms, most recently as the founder of the Richelieu Group Pty Ltd.

Other current directorships: Hocking Stuart Pty Ltd.

Special responsibilities: Chair of the Foundation.

 

 

Board Committees

 

PHI Foundation

  • The role of this committee is to provide the Institute with strategic advice and direction for fundraising, and building public and corporate awareness of PHI and its research.

  • Members: Mr John Weste (Chair), Professor Matthew Gillespie, Mr Ronnie Atlas, Mr Graeme Goldman, Mr Dylan Simmons, Miss Laura Watson (Secretary)

 

Finance and Audit Committee

  • The role of this committee is to assist the board in its oversight of the internal control and compliance, accounting and financial reporting, and risk management processes of PHI.

  • Members: Mr Stuart Alford (Chair), Ms Jane Bell, Dr Bob Edgar, Ms Carmel Mortell, Peter Murray (Secretary)

 

Investment Committee

  • Members: Dr Bob Edgar (Chair), Mr Martin O'Meara, Mr Richard Condon, Professor Jock Findlay, Professor Matthew Gillespie, Peter Murray (Secretary)

 

Intellectual Property and Commercialisation Committee

  • The role of this committee is to advise the Board and Director on statutory requirements for corporate governance and commercialisation of the institute's intellectual property and related issues.

  • Members: Mrs Jane Bell (Chair), Ms Jennifer Joiner, Mr Grant Fisher, Dr Michael Pannacio, Professor Matthew Gillespie, Associate Professor David Robertson, Professor Lois Salamonsen, Mr Andrew McCallum (Secretary)